Purpose: To determine the effectiveness of the experimental drug BAN2401 as a possible treatment for people with mild cognitive impairment or mild Alzheimer's disease.
Purpose: To compare the effectiveness of approved medications for treating Alzheimer's disease in participants from real-world memory care clinics.
Purpose: To identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Purpose: To develop and test the feasibility of using a specific pharmacological protocol to reduce delirium among older adults in the intensive care unit.